-
NeuroBo Pharmaceuticals filed a registration statement covering the potential sale of up to 5 million of its common shares to be offered by certain selling stockholders, as reported by Fidelity.
-
According to a filing with the US Securities and Exchange Commission, the offering consists of 2.5 million common shares held by the selling stockholders and 2.5 million shares issuable upon the exercise of outstanding warrants held by the selling stockholders.
To read more NewsPoints articles, click here.
